Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Int J Cancer. 2014 Oct 23;136(9):2047–2054. doi: 10.1002/ijc.29264

Figure 3.

Figure 3

Kaplan-Meier curve demonstrating significantly shorter tumor symptomatic tumor formation period in mice injected with RCAS-PDGFB + RCAS-STAT5b (median, 24 days; range, 12–90) vs. RCAS-PDGFB alone (median, 76.5 days; range, 23–90; log rank test, P = 0.0012; 95% CI: 2.65–3.73)